M M College of Pharmacy, M. M. (Deemed to be University), Mullana, Ambala, Haryana 133207, India.
Aragen Life Sciences Private Limited, Plot No. 28 A, IDA Nacharam, Hyderabad 500076, India.
Int J Pharm. 2021 Dec 15;610:121221. doi: 10.1016/j.ijpharm.2021.121221. Epub 2021 Oct 22.
The cassette dosing technique is employed in the drug discovery stage of non-clinical studies to obtain pharmacokinetic data from multiple drug candidates in a single experiment. The objective of the current investigation was to evaluate the effect of sex and food on the selected pharmacokinetic parameters of four biopharmaceutical classification system (BCS) drugs (BCS-I: propranolol, BCS-II: diclofenac, BCS-III: atenolol, and BCS-IV: acetazolamide) utilizing cassette dosing in male and female rats under fed and fasting conditions. Different animal groups were dosed intravenous (i.v) and oral at 1 and 10 mg/kg, respectively, in the form of cassette at a dose of 5 mL/kg. Blood samples were analyzed by liquid chromatography-tandem mass spectrometry. Pharmacokinetics parameters were calculated using Phoenix software version 8.1. A significant increase (p < 0.05) of the area under the plasma concentration-time (AUC) was observed for diclofenac and acetazolamide in females over males after i.v dosing. Additionally, acetazolamide showed greater instantaneous concentration at the time of dosing, and clearance in females (p < 0.05) compared to males after i.v administration. After oral dosing, propranolol exhibited significant variations (p < 0.05) in the maximum drug concentration (C), AUC, the volume of distribution (V), and bioavailability in females as compared to males under fed state. Diclofenac showed significant changes (p < 0.05) in AUC, and clearance (Cl) in females as compared to males under fasting and fed state. However, acetazolamide exhibited a significant enhancement (p < 0.05) in AUC, V, and Cl in fasting females than the males. The data here illustrates that there is an appreciable difference in AUC and C values exist in male and female rats under fed and fasting conditions administered with the cassette dosing of tested BCS class drugs.
在非临床研究的药物发现阶段,采用盒式给药技术从多个药物候选物中单次实验获得药代动力学数据。本研究旨在评估在禁食和进食条件下,利用盒式给药法,雄性和雌性大鼠的四种生物药剂学分类系统(BCS)药物(BCS-I:普萘洛尔;BCS-II:双氯芬酸;BCS-III:阿替洛尔;BCS-IV:乙酰唑胺)的性别和食物对选定药代动力学参数的影响。分别以 1 和 10mg/kg 的剂量,以 5mL/kg 的剂量进行盒式静脉(i.v.)和口服给药。采用液相色谱-串联质谱法分析血样。使用 Phoenix 软件版本 8.1 计算药代动力学参数。静脉给药后,女性的双氯芬酸和乙酰唑胺的 AUC 显著增加(p<0.05)。此外,与男性相比,女性的乙酰唑胺在静脉给药后的即时浓度更高,清除率也更高(p<0.05)。口服给药后,与男性相比,进食状态下,女性的普萘洛尔的 Cmax、AUC、分布容积(V)和生物利用度有显著差异(p<0.05)。与男性相比,禁食和进食状态下,双氯芬酸的 AUC 和清除率(Cl)在女性中也有显著变化(p<0.05)。然而,与男性相比,禁食女性的乙酰唑胺的 AUC、V 和 Cl 显著增强(p<0.05)。这些数据表明,在给予测试 BCS 类药物的盒式给药后,进食和禁食状态下雄性和雌性大鼠的 AUC 和 C 值存在明显差异。